The clinical application of specific, biologically active compounds—metabolites—produced by the commensal gut microbiota to exert therapeutic effects on the host’s physiology. This therapy leverages molecules like short-chain fatty acids (SCFAs) and secondary bile acids to modulate immune function, hormone signaling, and neurological health. It represents a targeted, post-biotic approach to leveraging the benefits of the gut microbiome.
Origin
The term combines ‘microbial,’ referring to the gut flora, with ‘metabolite,’ a biochemical term for the end products of metabolic processes. ‘Therapy’ denotes the intentional use of these compounds for clinical benefit. This approach is a sophisticated evolution of traditional probiotic and prebiotic strategies.
Mechanism
The mechanism is based on the direct interaction of microbial metabolites with host cell receptors and signaling pathways. For example, SCFAs like butyrate and propionate bind to G-protein coupled receptors (GPCRs) on colonocytes and immune cells, triggering anti-inflammatory and metabolic responses. These metabolites also act as signaling molecules in the gut-brain axis, influencing satiety and mood regulation, thereby directly linking gut health to systemic function.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.